Immune-Engineered Device Targets Chemo-Resistant Lymphoma

News The Cornell team has developed a "lymphoma micro-reactor" device that exposes human lymphomas to fluid flow similar to that in the lymphatics and parts of the lymph node... Contributed Author: Cornell University Topics: Oncology